R M Harvey - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R M Harvey

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Scientific Reports|September 8, 2022

Tau isoform-specific enhancement of L-type calcium current and augmentation of afterhyperpolarization in rat hippocampal neuronsGeorgiana F Stan, Timothy W Church, Ellie Randall, et al.

ACS Medicinal Chemistry Letters|May 15, 2024

Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.

Journal of Medicinal Chemistry|August 31, 2023

Discovery of <b>CVN417</b>, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor DysfunctionLouisa A Christie, Nicola L Brice, Anna Rowland, et al.

ACS Medicinal Chemistry Letters|February 18, 2026

Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.

Frontiers in Neuroscience|September 17, 2025

NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasiaGiuliano G Stirparo, Xiao Xu, Toni Thompson, et al.

Neuropharmacology|November 14, 2022

Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Scientific Reports|September 8, 2022

Tau isoform-specific enhancement of L-type calcium current and augmentation of afterhyperpolarization in rat hippocampal neuronsGeorgiana F Stan, Timothy W Church, Ellie Randall, et al.

ACS Medicinal Chemistry Letters|May 15, 2024

Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.

Journal of Medicinal Chemistry|August 31, 2023

Discovery of <b>CVN417</b>, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor DysfunctionLouisa A Christie, Nicola L Brice, Anna Rowland, et al.

ACS Medicinal Chemistry Letters|February 18, 2026

Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.

Frontiers in Neuroscience|September 17, 2025

NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasiaGiuliano G Stirparo, Xiao Xu, Toni Thompson, et al.

Neuropharmacology|November 14, 2022

Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.

Pageof 2